Completed OBSERVATIONAL NCT04839588

Telerehabilitation Cognitive Impairments Following Chemotherapy Usability Study (TCIFCU)

Home-based Virtual Reality System for the Treatment of Chemotherapy-related Cognitive Impairments

Sponsor: Bright Cloud International Corp

Conditions Chemotherapy-Related Cognitive Impairment Healthy

Updated 5 times since 2021 Last updated: Apr 27, 2022 Started: Jun 7, 2021 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chemotherapy-Related Cognitive Impairment and Healthy and is currently completed. Bright Cloud International Corp leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Sep 2021 — May 2022 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
May 2021 — Sep 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bright Cloud International Corp
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey

Data source: Bright Cloud International Corp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• North Brunswick, United States